logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Malignant Neoplasms

    FiltersReset Filters
    6 results

    • diazoxide

      (Diazoxide)
      Par Pharmaceutical, Inc
      Usage: Diazoxide oral suspension is indicated for managing hypoglycemia due to hyperinsulinism in adults (e.g., inoperable islet cell tumors) and in infants/children (e.g., leucine sensitivity, islet cell hyperplasia). It is used temporarily preoperatively or postoperatively when hypoglycemia persists after other treatments fail.

    • fludeoxyglucose f 18

      (Fludeoxyglucose F 18)
      PETNET Solutions, Inc.
      Usage: Fludeoxyglucose F 18 Injection is indicated for PET imaging in oncology to assess glucose metabolism in malignancies, in cardiology to identify myocardial function in coronary artery disease, and in neurology to locate abnormal glucose metabolism related to epileptic seizures.

    • fludeoxyglucose f 18

      (Fludeoxyglucose F-18)
      Mayo Clinic
      Usage: Fludeoxyglucose F 18 Injection USP is indicated for PET imaging in oncology to assess glucose metabolism in cancer evaluation, cardiology to identify myocardial function in coronary artery disease, and neurology to locate abnormal glucose metabolism in epileptic seizures.

    • leukine

      (SARGRAMOSTIM)
      Partner Therapeutics, Inc.
      Usage: LEUKINE is indicated for shortening neutrophil recovery and reducing severe infections in adults with acute myeloid leukemia post-chemotherapy, mobilizing progenitor cells for transplantation, accelerating recovery in bone marrow transplants, treating delayed neutrophil recovery, and increasing survival after acute exposure to myelosuppressive radiation in patients up to 17 years.

    • neupogen

      (Filgrastim)
      Amgen Inc
      Usage: NEUPOGEN is indicated for reducing infection risk in cancer patients receiving myelosuppressive chemotherapy, accelerating neutrophil recovery in acute myeloid leukemia, decreasing neutropenia duration in bone marrow transplant patients, mobilizing progenitor cells for collection, treating severe chronic neutropenia, and enhancing survival after myelosuppressive radiation exposure.

    • nivestym

      (filgrastim-aafi)
      Pfizer Laboratories Div Pfizer Inc
      Usage: NIVESTYM is indicated to decrease infection risk in cancer patients receiving myelosuppressive chemotherapy, promote neutrophil recovery in acute myeloid leukemia, reduce neutropenia duration in bone marrow transplant patients, aid in autologous stem cell collection, and manage symptoms in severe chronic neutropenia patients.